Literature DB >> 3323645

[Serologic AIDS diagnosis with polypeptides obtained by genetic technics of the human immunodeficiency virus (HIV-1)].

A Lenz1, J von Hintzenstern, O Erlwein, S Ellinger, M Bröker, B Fleckenstein, G Jahn.   

Abstract

Serologic testing for human immunodeficiency virus type 1 (HIV-1) is currently based on enzyme linked immunosorbent assay (ELISA) as screening method. Positive ELISA-results have to be confirmed by at least one second procedure such as Western blotting or immunofluorescence. To obtain new diagnostic reagents for confirmatory testing, we expressed viral antigens in procaryotic systems. Peptides representing epitopes of structural core (gag)- and envelope (env)-proteins of HIV were produced in E. coli as stable immunogenic beta-galactosidase fusion proteins. Recombinant proteins were taken for immunoblot-assays. The results of Western blotting with those fusion proteins were in general comparable with conventional ELISA, immunofluorescence, immunoblot with cell-culture derived virus and commercially available ELISA tests based on recombinant proteins. Immunoblots using recombinant transmembrane protein (gp41) derived polypeptide were more sensitive than the conventional procedure with purified virion proteins. Western blotting with recombinant fusionproteins provide reliable and inexpensive serodiagnostics without handling of infectious cell cultures.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3323645     DOI: 10.1007/BF01726323

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  14 in total

1.  Complete nucleotide sequence of the AIDS virus, HTLV-III.

Authors:  L Ratner; W Haseltine; R Patarca; K J Livak; B Starcich; S F Josephs; E R Doran; J A Rafalski; E A Whitehorn; K Baumeister
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

2.  Update: acquired immunodeficiency syndrome--United States.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1986-12-12       Impact factor: 17.586

3.  The impact of the AIDS epidemic on corneal transplantation.

Authors:  J S Pepose; S Mac Rae; T C Quinn; G N Holland
Journal:  Am J Ophthalmol       Date:  1985-10-15       Impact factor: 5.258

4.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

5.  Bacterial expression of the acquired immunodeficiency syndrome retrovirus p24 gag protein and its use as a diagnostic reagent.

Authors:  D J Dowbenko; J R Bell; C V Benton; J E Groopman; H Nguyen; D Vetterlein; D J Capon; L A Lasky
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

6.  Diagnostic significance of quantitative determination of HIV antibody specific for envelope and core proteins.

Authors:  G G Frösner; V Erfle; W Mellert; R Hehlmann
Journal:  Lancet       Date:  1987-01-17       Impact factor: 79.321

7.  Differential antibody responses of individuals infected with AIDS-associated retroviruses surveyed using the viral core antigen p25gag expressed in bacteria.

Authors:  K S Steimer; J P Puma; M D Power; M A Powers; C George-Nascimento; J C Stephans; J A Levy; R Sanchez-Pescador; P A Luciw; P J Barr
Journal:  Virology       Date:  1986-04-15       Impact factor: 3.616

8.  HTLV-III in symptom-free seronegative persons.

Authors:  S Z Salahuddin; J E Groopman; P D Markham; M G Sarngadharan; R R Redfield; M F McLane; M Essex; A Sliski; R C Gallo
Journal:  Lancet       Date:  1984-12-22       Impact factor: 79.321

9.  Evaluation of six enzyme immunoassays for antibody against human immunodeficiency virus.

Authors:  H W Reesink; P N Lelie; J G Huisman; W Schaasberg; M Gonsalves; C Aaij; I N Winkel; J A van der Does; A C Hekker; J Desmyter
Journal:  Lancet       Date:  1986-08-30       Impact factor: 79.321

10.  Subregions of a conserved part of the HIV gp41 transmembrane protein are differentially recognized by antibodies of infected individuals.

Authors:  U Certa; W Bannwarth; D Stüber; R Gentz; M Lanzer; S Le Grice; F Guillot; I Wendler; G Hunsmann; H Bujard
Journal:  EMBO J       Date:  1986-11       Impact factor: 11.598

View more
  2 in total

1.  Delayed seroconversion to HIV in a hemophiliac.

Authors:  J von Hintzenstern; G Jahn; K Mang; D Harms; B Fleckenstein
Journal:  Klin Wochenschr       Date:  1988-05-02

2.  Cleavage of procaryotically expressed human immunodeficiency virus fusion proteins by factor Xa and application in western blot (immunoblot) assays.

Authors:  S Ellinger; R Glockshuber; G Jahn; A Plückthun
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.